159 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
as the result of previous process improvements, partially offset by a $1.3 million inventory write-off charge recorded during the first quarter of 2024 … and activities for planned clinical trials in 2024, partially offset by increases related to investments in our CpG 1018 preclinical and clinical
8-K
EX-99.1
0l1bg5 4gcaohaw5k
2 Nov 23
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:10pm
8-K
EX-99.1
0758nxb0
13 May 21
Dynavax Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
4:38pm
8-K
wxo72urp
13 May 21
Dynavax Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
4:38pm
8-K
EX-99.2
j1oafbfboorotkez
13 May 21
Dynavax Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
4:38pm